Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Markus Leweke

Showing results (71-80 of 120) with videos related to

Pageof 12
Sort By:
Journal of Clinical Psychopharmacology|October 2, 2003
Treatment of acute alcohol withdrawal with gabapentin: results from a controlled two-center trialUdo Bonnet, Markus Banger, F Markus Leweke, et al.
Fortschritte Der Neurologie-Psychiatrie|February 15, 2019
[The CIMH Track Concept in Psychiatry: Syndrome-specific Treatment across Modalities - Part 1 - Theoretical background]F Markus Leweke, Dusan Hirjak, Claus Staudter, et al.
Schizophrenia Bulletin|August 13, 2013
Identification of subgroups of schizophrenia patients with changes in either immune or growth factor and hormonal pathwaysEmanuel Schwarz, Nico J M van Beveren, Jordan Ramsey, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 24, 2009
Binocular depth inversion as a paradigm of reduced visual information processing in prodromal state, antipsychotic-naïve and treated schizophreniaDagmar Koethe, Laura Kranaster, Carolin Hoyer, et al.
Plos One|November 19, 2013
Distinct molecular phenotypes in male and female schizophrenia patientsJordan M Ramsey, Emanuel Schwarz, Paul C Guest, et al.
Neuroimage|April 30, 2013
Increased ventral striatal CB1 receptor binding is related to negative symptoms in drug-free patients with schizophreniaJenny Ceccarini, Marc De Hert, Ruud Van Winkel, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|October 14, 2016
Association of anandamide with altered binocular depth inversion illusion in schizophreniaAnne R Reuter, J Malte Bumb, Juliane K Mueller, et al.
Alcoholism, Clinical and Experimental Research|May 22, 2007
Oxcarbazepine--efficacy and tolerability during treatment of alcohol withdrawal: a double-blind, randomized, placebo-controlled multicenter pilot studyDagmar Koethe, Antje Juelicher, Brit M Nolden, et al.
Schizophrenia Research|September 29, 2006
Disturbances of visual information processing in early states of psychosis and experimental delta-9-tetrahydrocannabinol altered states of consciousnessDagmar Koethe, Christoph W Gerth, Miriam A Neatby, et al.
Schizophrenia Bulletin|April 19, 2014
Inflammatory molecular signature associated with infectious agents in psychosisLindsay N Hayes, Emily G Severance, Jeffrey T Leek, et al.
Pageof 12

Showing results (71-80 of 120) with videos related to

Sort By:
Pageof 12
Journal of Clinical Psychopharmacology|October 2, 2003
Treatment of acute alcohol withdrawal with gabapentin: results from a controlled two-center trialUdo Bonnet, Markus Banger, F Markus Leweke, et al.
Fortschritte Der Neurologie-Psychiatrie|February 15, 2019
[The CIMH Track Concept in Psychiatry: Syndrome-specific Treatment across Modalities - Part 1 - Theoretical background]F Markus Leweke, Dusan Hirjak, Claus Staudter, et al.
Schizophrenia Bulletin|August 13, 2013
Identification of subgroups of schizophrenia patients with changes in either immune or growth factor and hormonal pathwaysEmanuel Schwarz, Nico J M van Beveren, Jordan Ramsey, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 24, 2009
Binocular depth inversion as a paradigm of reduced visual information processing in prodromal state, antipsychotic-naïve and treated schizophreniaDagmar Koethe, Laura Kranaster, Carolin Hoyer, et al.
Plos One|November 19, 2013
Distinct molecular phenotypes in male and female schizophrenia patientsJordan M Ramsey, Emanuel Schwarz, Paul C Guest, et al.
Neuroimage|April 30, 2013
Increased ventral striatal CB1 receptor binding is related to negative symptoms in drug-free patients with schizophreniaJenny Ceccarini, Marc De Hert, Ruud Van Winkel, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|October 14, 2016
Association of anandamide with altered binocular depth inversion illusion in schizophreniaAnne R Reuter, J Malte Bumb, Juliane K Mueller, et al.
Alcoholism, Clinical and Experimental Research|May 22, 2007
Oxcarbazepine--efficacy and tolerability during treatment of alcohol withdrawal: a double-blind, randomized, placebo-controlled multicenter pilot studyDagmar Koethe, Antje Juelicher, Brit M Nolden, et al.
Schizophrenia Research|September 29, 2006
Disturbances of visual information processing in early states of psychosis and experimental delta-9-tetrahydrocannabinol altered states of consciousnessDagmar Koethe, Christoph W Gerth, Miriam A Neatby, et al.
Schizophrenia Bulletin|April 19, 2014
Inflammatory molecular signature associated with infectious agents in psychosisLindsay N Hayes, Emily G Severance, Jeffrey T Leek, et al.
Pageof 12